Gene · 338442
Papers1,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 3-Hydroxybutyrate Promotes Myoblast Proliferation and Differentiation through Energy Metabolism and GPR109a-Mediated Ca2+-NFAT Signaling Pathways. | J Proteome Res | 2025 | 40099866 | PubTator, text mining | PubMed |
| Angelicin ameliorated ulcerative colitis through activating HDAC1-derived HIF-1α acetylation. | Phytomedicine | 2025 | 40058317 | PubTator, text mining | PubMed |
| Microbial Butyrate Modified by Melatonin Alleviates Colon Inflammation by Inhibiting GPR109A/Caspase-1-Dependent Macrophage M1 Polarization. | J Proteome Res | 2025 | 40042189 | PubTator, text mining | PubMed |
| Therapeutic effects of amisulpride in male schizophrenics: Role of short-chain fatty acids and gene expression changes. | Physiol Behav | 2025 | 40020893 | PubTator, text mining | PubMed |
| Restorative Effects of Short-Chain Fatty Acids on Corneal Homeostasis Disrupted by Antibiotic-Induced Gut Dysbiosis. | Am J Pathol | 2025 | 39732390 | PubTator, text mining | PubMed |
| Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A+ myeloid cells to promote liver cancer progression. | Gut | 2025 | 38981667 | PubTator, text mining | PubMed |
Anthranilic Acid-G-Protein Coupled Receptor109A-Cytosolic Phospholipase A2-Myelin-Cognition Cascade: A New Target for the Treatment/Prevention of Cognitive Impairment in Schizophrenia, Dementia, and Aging. | Int J Mol Sci | 2024 | 39769034 | PubTator, text mining | PubMed |
| Oral Astragalus polysaccharide alleviates adenine-induced kidney injury by regulating gut microbiota-short-chain fatty acids-kidney G protein-coupled receptors axis. | Ren Fail | 2024 | 39603250 | PubTator, text mining | PubMed |
| Shen-Bai-Jie-Du decoction suppresses the progression of colorectal adenoma to carcinoma through regulating gut microbiota and short-chain fatty acids. | Chin Med | 2024 | 39465423 | PubTator, text mining | PubMed |
| The hydroxycarboxylic acid receptor HCA2 is required for the protective effect of ketogenic diet in epilepsy. | Pharmacol Res Perspect | 2024 | 39439218 | PubTator, text mining | PubMed |
| Structural basis for ligand recognition of the human hydroxycarboxylic acid receptor HCAR3. | Cell Rep | 2024 | 39427321 | PubTator, text mining | PubMed |
| Niacin-induced flushing: Mechanism, pathophysiology, and future perspectives. | Arch Biochem Biophys | 2024 | 39322100 | PubTator, text mining | PubMed |
| A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages. | Biochim Biophys Acta Mol Basis Dis | 2024 | 39233260 | PubTator, text mining | PubMed |
| β-Hydroxybutyrate enhances chondrocyte mitophagy and reduces cartilage degeneration in osteoarthritis via the HCAR2/AMPK/PINK1/Parkin pathway. | Aging Cell | 2024 | 39126207 | PubTator, text mining | PubMed |
| Salidroside Alleviates Furan-Induced Impaired Gut Barrier and Inflammation via Gut Microbiota-SCFA-TLR4 Signaling. | J Agric Food Chem | 2024 | 38990698 | PubTator, text mining | PubMed |
| Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode. | Nat Commun | 2024 | 38918366 | PubTator, text mining | PubMed |
| Microbial metabolite butyrate modulates granzyme B in tolerogenic IL-10 producing Th1 cells to regulate intestinal inflammation. | Gut Microbes | 2024 | 38841892 | PubTator, text mining | PubMed |
| Exploring Microbial Metabolite Receptors in Inflammatory Bowel Disease: An In Silico Analysis of Their Potential Role in Inflammation and Fibrosis. | Pharmaceuticals (Basel) | 2024 | 38675452 | PubTator, text mining | PubMed |
| Management of Cardiovascular Diseases by Short-Chain Fatty Acid Postbiotics. | Curr Nutr Rep | 2024 | 38656688 | PubTator, text mining | PubMed |
| The effect of oral butyrate on colonic short-chain fatty acid transporters and receptors depends on microbial status. | Front Pharmacol | 2024 | 38595917 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338442/papers?page=6